Abiopharma

🔍 WOLF DALE B (Director)

Company: AdaptHealth Corp. (AHCO)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 20,000 shares of Common Stock at $6.37 per share (Direct)
  Date: 2026-08-06 | Code: P | equity_swap_involved: 0 | shares_owned_after: 143,234.00 | transaction_form_type: 4
• Acquired 20,000 shares of Common Stock at $5.86 per share (Direct)
  Date: 2026-08-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 34,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.83 to $5.885, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
• F2: Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.
• REMARKS: *** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.